93 related articles for article (PubMed ID: 22336879)
21. Immunogenicity and effectiveness of an mRNA therapeutic vaccine for HPV-related malignancies.
Wang J; Ma L; Chen Y; Zhou R; Wang Q; Zhang T; Yi D; Liu Q; Zhang Y; Zhang W; Dong Y; Cen S
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38514186
[TBL] [Abstract][Full Text] [Related]
22. T-cell responses to the M3 immune evasion protein of murid gammaherpesvirus 68 are partially protective and induced with lytic antigen kinetics.
Obar JJ; Donovan DC; Crist SG; Silvia O; Stewart JP; Usherwood EJ
J Virol; 2004 Oct; 78(19):10829-32. PubMed ID: 15367651
[TBL] [Abstract][Full Text] [Related]
23. Production of recombinant HPV11/16 E6/E7-MBP-His
Xu MN; Zhong MZ; Feng SN; Xu YQ; Peng XM; Zeng K; Huang XW
Virol J; 2024 Jan; 21(1):10. PubMed ID: 38183109
[TBL] [Abstract][Full Text] [Related]
24. Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth.
Liu DW; Tsao YP; Hsieh CH; Hsieh JT; Kung JT; Chiang CL; Huang SJ; Chen SL
J Virol; 2000 Oct; 74(19):9083-9. PubMed ID: 10982354
[TBL] [Abstract][Full Text] [Related]
25. Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies.
Wang J; Wang Q; Ma L; Lv K; Han L; Chen Y; Zhou R; Zhou H; Chen H; Wang Y; Zhang T; Yi D; Liu Q; Zhang Y; Li X; Cheng T; Zhang J; Huang C; Dong Y; Zhang W; Cen S
Mol Ther; 2024 May; ():. PubMed ID: 38715363
[TBL] [Abstract][Full Text] [Related]
26. STAT1-Deficient HPV E6/E7-Associated Cancers Maintain Host Immunocompetency against Therapeutic Intervention.
Lim L; Hu MH; Fan D; Tu HF; Tsai YC; Cheng M; Wang S; Chang CL; Wu TC; Hung CF
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675812
[TBL] [Abstract][Full Text] [Related]
27. Preclinical Immunogenicity and Efficacy Studies for Therapeutic Vaccines for Human Papillomavirus-Type-16-Associated Cancer.
Mohammadi M; Saha A; Giles-Davis W; Xiang Z; Novikov M; Hasanpourghadi M; C J Ertl H
Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932345
[TBL] [Abstract][Full Text] [Related]
28. Serum IgG antibodies to HPV6 L1, E2, E4, E6, and E7 proteins among children prospectively followed-up for three years.
Suominen H; Syrjänen K; Waterboer T; Grénman S; Syrjänen S; Louvanto K
J Infect Dis; 2024 May; ():. PubMed ID: 38820118
[TBL] [Abstract][Full Text] [Related]
29. T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.
Fert I; Douguet L; Vesin B; Moncoq F; Noirat A; Authié P; Ciret S; Le Chevalier F; Blanc C; Vitrenko Y; Charneau P; Majlessi L; Anna F
NPJ Vaccines; 2024 Jun; 9(1):102. PubMed ID: 38858404
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11-001.
Miles B; Safran HP; Monk BJ
Gynecol Oncol Res Pract; 2017; 4():10. PubMed ID: 28725449
[TBL] [Abstract][Full Text] [Related]
31. Correction: Long-term antigen-specific immune response by an oncolytic adenovirus encoding SP-SA-E7-4-1BBL in HPV-16 cancer model.
Martinez-Perez AG; Garza-Morales R; de Loera-Arias MJ; Villa-Cedillo SA; Garcia-Garcia A; Rodriguez-Rocha H; Flores-Maldonado OE; Valdes J; Perez-Trujillo JJ; Saucedo-Cardenas O
Mol Biol Rep; 2024 Apr; 51(1):565. PubMed ID: 38649646
[No Abstract] [Full Text] [Related]
32. Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients.
Kim TJ; Jin HT; Hur SY; Yang HG; Seo YB; Hong SR; Lee CW; Kim S; Woo JW; Park KS; Hwang YY; Park J; Lee IH; Lim KT; Lee KH; Jeong MS; Surh CD; Suh YS; Park JS; Sung YC
Nat Commun; 2014 Oct; 5():5317. PubMed ID: 25354725
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.
Bagarazzi ML; Yan J; Morrow MP; Shen X; Parker RL; Lee JC; Giffear M; Pankhong P; Khan AS; Broderick KE; Knott C; Lin F; Boyer JD; Draghia-Akli R; White CJ; Kim JJ; Weiner DB; Sardesai NY
Sci Transl Med; 2012 Oct; 4(155):155ra138. PubMed ID: 23052295
[TBL] [Abstract][Full Text] [Related]
34. Cervical Cancer Immunotherapy: Facts and Hopes.
Ferrall L; Lin KY; Roden RBS; Hung CF; Wu TC
Clin Cancer Res; 2021 Sep; 27(18):4953-4973. PubMed ID: 33888488
[TBL] [Abstract][Full Text] [Related]
35. Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis.
Aggarwal C; Cohen RB; Morrow MP; Kraynyak KA; Sylvester AJ; Cheung J; Dickerson K; Schulten V; Knoblock D; Gillespie E; Bauml JM; Yan J; Diehl M; Boyer J; Dallas M; Kim JJ; Weiner DB; Skolnik JM
Vaccines (Basel); 2020 Jan; 8(1):. PubMed ID: 32013270
[TBL] [Abstract][Full Text] [Related]
36. Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes.
Di Bonito P; Accardi L; Galati L; Ferrantelli F; Federico M
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30682811
[TBL] [Abstract][Full Text] [Related]
37. Low risk HPV-6E6 induces apoptosis in bone marrow-derived dendritic cells.
Sun L; Zhao L; Li D; Xu S; Hou X; Li Z
Oncol Lett; 2018 Jan; 15(1):1157-1162. PubMed ID: 29422974
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.
Cheng MA; Farmer E; Huang C; Lin J; Hung CF; Wu TC
Hum Gene Ther; 2018 Sep; 29(9):971-996. PubMed ID: 29316817
[TBL] [Abstract][Full Text] [Related]
39. Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer.
Veglia F; Tyurin VA; Mohammadyani D; Blasi M; Duperret EK; Donthireddy L; Hashimoto A; Kapralov A; Amoscato A; Angelini R; Patel S; Alicea-Torres K; Weiner D; Murphy ME; Klein-Seetharaman J; Celis E; Kagan VE; Gabrilovich DI
Nat Commun; 2017 Dec; 8(1):2122. PubMed ID: 29242535
[TBL] [Abstract][Full Text] [Related]
40. Identification of the murine H-2D(b) and human HLA-A*0201 MHC class I-restricted HPV6 E7-specific cytotoxic T lymphocyte epitopes.
Peng S; Mattox A; Best SR; Barbu AM; Burns JA; Akpeng B; Jeang J; Yang B; Ishida E; Hung CF; Wu TC; Pai SI
Cancer Immunol Immunother; 2016 Mar; 65(3):261-71. PubMed ID: 26759151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
